Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Wada

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Cancer Science|March 16, 2004
Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) miceItsuro Takada, Yuji Noguchi, Akira Kenjo, et al.
Anticancer Research|April 28, 2026
PD-1<sup>+</sup>Tim-3<sup>+</sup>CD103<sup>+</sup> CD8<sup>+</sup> Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal CancerDaijiro Matoba, Takuro Saito, Takehiro Noda, et al.
Scientific Reports|November 25, 2025
The relationship between galectin-1 expression and the efficacy of anti-PD-1 therapy for non-small cell lung cancer patientsMari Tone, Yukihiro Yano, Junji Uchida, et al.
Scientific Reports|November 21, 2025
Lung tissue T cells are activated in chronic obstructive pulmonary disease with non-small cell lung cancer patientsMari Tone, Tomomi Isono, Yoko Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
Requirement for intron structures in activating the <i>Cd8a</i> locusHisashi Wada, Nighat Yasmin, Kiyokazu Kakugawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2023
Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell ProfileAzumi Ueyama, Wataru Nogami, Kunitaka Nashiki, et al.
Biological & Pharmaceutical Bulletin|April 4, 2022
Tetracyclines Enhance Anti-tumor T-Cell Responses Induced by a Bispecific T-Cell EngagerYuki Noguchi, Yoko Yamamoto, Kota Iwahori, et al.
Anticancer Research|August 28, 2024
<i>Helicobacter pylori</i> Infection Affects the Tumor Immune Microenvironment of Esophageal Cancer PatientsHiroki Matsuda, Kota Iwahori, Tomohira Takeoka, et al.
Annals of Gastroenterological Surgery|March 8, 2024
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancerJunji Kawada, Takuro Saito, Yukinori Kurokawa, et al.
Vaccine|September 15, 2014
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccineTakuro Saito, Hisashi Wada, Makoto Yamasaki, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Cancer Science|March 16, 2004
Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) miceItsuro Takada, Yuji Noguchi, Akira Kenjo, et al.
Anticancer Research|April 28, 2026
PD-1<sup>+</sup>Tim-3<sup>+</sup>CD103<sup>+</sup> CD8<sup>+</sup> Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal CancerDaijiro Matoba, Takuro Saito, Takehiro Noda, et al.
Scientific Reports|November 25, 2025
The relationship between galectin-1 expression and the efficacy of anti-PD-1 therapy for non-small cell lung cancer patientsMari Tone, Yukihiro Yano, Junji Uchida, et al.
Scientific Reports|November 21, 2025
Lung tissue T cells are activated in chronic obstructive pulmonary disease with non-small cell lung cancer patientsMari Tone, Tomomi Isono, Yoko Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
Requirement for intron structures in activating the <i>Cd8a</i> locusHisashi Wada, Nighat Yasmin, Kiyokazu Kakugawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2023
Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell ProfileAzumi Ueyama, Wataru Nogami, Kunitaka Nashiki, et al.
Biological & Pharmaceutical Bulletin|April 4, 2022
Tetracyclines Enhance Anti-tumor T-Cell Responses Induced by a Bispecific T-Cell EngagerYuki Noguchi, Yoko Yamamoto, Kota Iwahori, et al.
Anticancer Research|August 28, 2024
<i>Helicobacter pylori</i> Infection Affects the Tumor Immune Microenvironment of Esophageal Cancer PatientsHiroki Matsuda, Kota Iwahori, Tomohira Takeoka, et al.
Annals of Gastroenterological Surgery|March 8, 2024
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancerJunji Kawada, Takuro Saito, Yukinori Kurokawa, et al.
Vaccine|September 15, 2014
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccineTakuro Saito, Hisashi Wada, Makoto Yamasaki, et al.
Pageof 10